glycyrrhizic acid has been researched along with Adenocarcinoma, Basal Cell in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, GG; Deng, QP; Huang, RY; Wang, MJ; Zeng, X | 1 |
Chen, XM; Chu, YL; Huang, RY; Jiang, ZB; Zeng, X; Zhang, X | 1 |
Cai, Q; Chen, X; Harris, RC; Kon, V; Pozzi, A; Shrubsole, MJ; Xu, J; Yao, B; Yin, H; Zhang, MZ; Zheng, W | 1 |
Jang, ER; Kim, W; Kim, YJ; Lee, CS; Myung, SC; Yang, JC | 1 |
4 other study(ies) available for glycyrrhizic acid and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma.
Topics: A549 Cells; Adenocarcinoma; Animals; Cisplatin; Female; Glycyrrhizic Acid; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Xenograft Model Antitumor Assays | 2017 |
Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Gene Knockdown Techniques; Glycyrrhizic Acid; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Proteins; Thromboxane-A Synthase | 2014 |
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adenocarcinoma; Adenoma; Animals; Base Sequence; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Gene Silencing; Genes, APC; Glycyrrhizic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Models, Biological; Neovascularization, Pathologic; Receptors, Glucocorticoid; RNA, Small Interfering | 2009 |
18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; Drug Synergism; Enzyme Activation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mitochondria; Ovarian Neoplasms; Prodrugs; Tumor Suppressor Protein p53 | 2010 |